Sign In
Buy CLPT
$14.94
+0.360 (+2.47%)
At Close: Jul 31, 2026
Clearpoint Neuro, Inc. (CLPT) CEO Joseph Burnett on Q4 2020 Results - Earnings Call Transcript
10:51pm, Thursday, 04'th Mar 2021
Clearpoint Neuro, Inc. (CLPT) CEO Joseph Burnett on Q4 2020 Results - Earnings Call Transcript
ClearPoint Neuro, Inc. (CLPT) Reports Q4 Loss, Tops Revenue Estimates
07:43pm, Thursday, 04'th Mar 2021
ClearPoint Neuro, Inc. (CLPT) delivered earnings and revenue surprises of 30.77% and 0.43%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stoc
Recap: ClearPoint Neuro Q4 Earnings
04:33pm, Thursday, 04'th Mar 2021
Shares of ClearPoint Neuro (NASDAQ:CLPT) were flat in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 18.18% over the past year to ($0.09), which
ClearPoint Neuro Reports Fourth Quarter and Full-Year 2020 Results
04:05pm, Thursday, 04'th Mar 2021
Company Reports Record Revenues
ClearPoint Neuro Announces Closing of Public Offering of 2,127,660 Shares of Common Stock
04:05pm, Tuesday, 23'rd Feb 2021
IRVINE, Calif., Feb. 23, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain,
ClearPoint Neuro to Announce Fourth Quarter and Full Year 2020 Results on March 4, 2021
04:05pm, Friday, 19'th Feb 2021
IRVINE, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain,
ClearPoint Neuro Secures $43M Via Equity At 9% Discount
05:56am, Friday, 19'th Feb 2021
ClearPoint Neuro Inc (NASDAQ: CLPT) has priced its underwritten public offering of 1.85 million shares at $23.50 per share, representing a 9% discount on the last close price of $25.80 on Thursday
ClearPoint Neuro Announces Pricing of Public Offering of 1,850,140 Shares of Common Stock
10:10pm, Thursday, 18'th Feb 2021
IRVINE, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain,
ClearPoint Neuro Launches Proposed Public Offering of Common Stock
04:35pm, Thursday, 18'th Feb 2021
IRVINE, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain,
ClearPoint Neuro, Inc. Announces License and Research Agreement with Philips
04:05pm, Thursday, 18'th Feb 2021
Collaboration will Enable ClearPoint to Develop and Launch the ClearPoint ‘Maestro™' Brain Model by 2022
ClearPoint Neuro, Inc. Announces Appointment of R. John Fletcher as Chairman of the Board of Directors
08:00am, Friday, 05'th Feb 2021
IRVINE, Calif., Feb. 05, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”) today announced that R. John Fletcher has been appointed Chairman of the Company's Board of
IRVINE, Calif., Jan. 26, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that
ClearPoint Neuro, Inc. Announces First Procedure Utilizing ClearPoint® 2.0 Software in Europe
04:05pm, Thursday, 14'th Jan 2021
IRVINE, Calif., Jan. 14, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT), a global therapy-enabling platform company providing navigation and delivery to the brain, today reported the f
ClearPoint Neuro, Inc. Reports Record Revenue in Preliminary Fourth Quarter 2020 Results
04:05pm, Tuesday, 12'th Jan 2021
IRVINE, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain,
ClearPoint Neuro, Inc. Announces Funding of Additional $7.5M of Existing Convertible Note on Improved Terms
04:15pm, Tuesday, 29'th Dec 2020
Represents Draw of Additional Proceeds from Petrichor Announced in January 2020 Represents Draw of Additional Proceeds from Petrichor Announced in January 2020
